Citation: Ruixuan Chen, Ping Ouyang, Licong Su, Xi Xu, Penghu Lian, Yanqin Li, Qi Gao, Yifan Zhang, Sheng Nie, Fan Luo, Ruqi Xu, Xiaodong Zhang, Xiaoxi Li, Yue Cao, Peiyan Gao, Juanjuan Kang, Jun Wu, Lu Li. Nanoparticles targeting at methylases with high correlation to N⁶-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma[J]. Chinese Chemical Letters, ;2022, 33(10): 4610-4616. doi: 10.1016/j.cclet.2022.03.074 shu

Nanoparticles targeting at methylases with high correlation to N⁶-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma

Ruixuan Chen ^{a, 1} ,
Ping Ouyang ^{b, 1} ,
Licong Su ^{a, 1} ,
Xi Xu ^{c, 1} ,
Penghu Lian ^{d, 1} ,
Yanqin Li ^a ,
Qi Gao ^a ,
Yifan Zhang ^e ,
Sheng Nie ^a ,
Fan Luo ^a ,
Ruqi Xu ^a ,
Xiaodong Zhang ^a ,
Xiaoxi Li ^b ,
Yue Cao ^a ,
Peiyan Gao ^a ,
Juanjuan Kang ^{f, *,} ,
Jun Wu ^{g, *,} ,
Lu Li ^{h, *,}

a.
National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Clinical Research Center for Kidney Disease, Nanfang Hospital, Southern Medical University, Guangzhou 510000, China
b.
Department of Health Management, Nanfang Hospital, Southern Medical University, Guangzhou 510000, China
c.
Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510000, China
d.
Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing 100730, China
e.
Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510000, China
f.
Affiliated Foshan Maternity & Child Healthcare Hospital, Southern Medical University, Foshan 528000, China
g.
School of Biomedical Engineering, Sun Yat-sen University, Shenzhen 518107, China
h.
Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou 510000, China

juanjuankang1108@gmail.com

wujun29@mail.sysu.edu.cn

173405790@qq.com

Received Date: 10 December 2021
Revised Date: 15 March 2022
Accepted Date: 17 March 2022
Available Online: 19 March 2022

Figures(4)

Clear cell renal cell carcinoma (ccRCC) is a heterogeneous malignancy with poor prognosis. Methylation of the N⁶ position of adenosine (m⁶A), the most common epigenetic modification in both messenger RNAs and noncoding RNAs, has been reported to regulate the initiation and progression of ccRCC. However, whether and how m⁶A-related long noncoding RNAs (m⁶ArlncRNAs) signify the progression of ccRCC remain unclear. We found m⁶ArlncRNAs are effective signatures illustrating immune landscape and risk stratification in ccRCC. We identified two differently expressed m⁶ArlncRNAs (DEm⁶ArlncRNAs), AC008870.2 and EMX2OS, as independent risk factors for overall survival of ccRCC patients, by applying stringent variable selection procedure to data from the Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma project. The risk score generated from the DEm⁶ArlncRNA expression categorizes patients into either high or low-risk groups, between which, enrichment analysis indicated an enrichment in immunerelated pathways. Under different DEm⁶ArlncRNA transcription pattern, the two risk groups differ in immune cell population composition and expression levels of therapy targeting genes. Nanoparticle is satisfactory strategy to delivering therapeutic drugs. For further clinical translation, we designed a novel nanoparticle delivery system packaged STM2457 (STM@8P4 NPs), which selectively inhibits AC008870.2- correlated m⁶A writer. STM@8P4 NPs loaded drug successfully with uniform particle size, long-term stability and high release efficiency. STM@8P4 NPs can easily enter ccRCC cells and showed a highly efficient ccRCC killing activity in vitro. Our results therefore indicate that m⁶ArlncRNAs expression can depict tumor microenvironment, predict prognosis for ccRCC patient and give hint to therapeutic strategies in ccRCC.
- Nanoparticle,
- Methylation,
- Long noncoding RNA,
- Clear cell renal carcinoma,
- Immunotherapy
1. [1]
  W.M. Linehan, C.J. Ricketts, Nat. Rev. Urol.16 (2019) 539-552. doi: 10.1038/s41585-019-0211-5
2. [2]
  J.J. Hsieh, M.P. Purdue, S. Signoretti, et al., Nat. Rev. Dis. Primers 3 (2017) 17009. doi: 10.1038/nrdp.2017.9
3. [3]
  L. Vuong, R.R. Kotecha, M.H. Voss, et al., Cancer Discov. 9 (2019) 1349-1357. doi: 10.1158/2159-8290.cd-19-0499
4. [4]
  Y. Şenbabaoğlu, R.S. Gejman, A.G. Winer, et al., Genome Biol. 17 (2016) 231. doi: 10.1186/s13059-016-1092-z
5. [5]
  K. Yoshihara, M. Shahmoradgoli, E. Martínez, et al., Nat. Commun. 4 (2013) 2612. doi: 10.1038/ncomms3612
6. [6]
  C.M. Díaz-Montero, B.I. Rini, J.H. Finke, Nat. Rev. Nephrol. 16 (2020) 721-735. doi: 10.1038/s41581-020-0316-3
7. [7]
  H. Coker, G. Wei, N. Brockdorff, Biochim. Biophys. Acta: Gene Regul. Mech. 1862 (2019) 310-318. doi: 10.1016/j.bbagrm.2018.12.002
8. [8]
  Y. Luo, J. Yang, J. Yu, et al., Front. Oncol. 10 (2020) 48. doi: 10.3389/fonc.2020.00048
9. [9]
  Y. Xiao, K.N. Thakkar, H. Zhao, et al., Proc. Natl. Acad. Sci. U. S. A. 117 (2020) 21441-21449. doi: 10.1073/pnas.2000516117
10. [10]
  T. Xu, S. Gao, H. Ruan, et al., Front. Genet. 12 (2021) 609174. doi: 10.3389/fgene.2021.609174
11. [11]
  E. Yankova, W. Blackaby, M. Albertella, et al., Nature 593 (2021) 597-601. doi: 10.1038/s41586-021-03536-w
12. [12]
  Y. Huang, R. Su, Y. Sheng, et al., Cancer Cell 35 (2019) 677-691. doi: 10.1016/j.ccell.2019.03.006
13. [13]
  Z. Li, J. Huang, T. Du, et al., Chin. Chem. Lett. 33 (2022) 2496–2500.. doi: 10.1016/j.cclet.2021.11.078
14. [14]
  U.A. Ashfaq, M. Riaz, E. Yasmeen, et al., Crit. Rev. Ther. Drug Carrier Syst. 34 (2017) 317-353. doi: 10.1615/CritRevTherDrugCarrierSyst.2017017845
15. [15]
  J. Xie, Y. Lu, B. Yu, et al., Chin. Chem. Lett. 31 (2020) 1173-1177. doi: 10.1016/j.cclet.2019.10.030
16. [16]
  C. Xian, Q. Yuan, Z. Bao, et al., Chin. Chem. Lett. 31 (2020) 19-27. doi: 10.1016/j.cclet.2019.03.052
17. [17]
  X. Wang, J. Sheng, M. Yang, Chin. Chem. Lett. 30 (2019) 533-540. doi: 10.1016/j.cclet.2018.10.010
18. [18]
  D. Bobo, K.J. Robinson, J. Islam, et al., Pharm. Res. -Dordr. 33 (2016) 2373-2387. doi: 10.1007/s11095-016-1958-5
19. [19]
  J. Huang, X. You, P. Xin, et al., Chin. Chem. Lett. 32 (2021) 1737-1742. doi: 10.1016/j.cclet.2020.12.006
20. [20]
  B. Chu, Y. Qu, X. He, et al., Adv. Funct. Mater. 30 (2020) 2005918. doi: 10.1002/adfm.202005918
21. [21]
  Y. Qu, B. Chu, X. Wei, et al., Adv. Mater. (2021) 2107883.
22. [22]
  C.S. Huang, X. You, C. Dai, et al., Adv. Sci. 7 (2020) 1902926. doi: 10.1002/advs.201902926
23. [23]
  H. Guo, F. Li, H. Qiu, et al., Research 2020 (2020) 1-14.
24. [24]
  F. Ordikhani, V. Kasinath, M. Uehara, et al., Nano Today 35 (2020). doi: 10.1016/j.nantod.2020.100990
25. [25]
  Z. Sun, C. Jing, C. Xiao, et al., Aging (Albany NY) 12 (2020) 22078-22094. doi: 10.18632/aging.104053
26. [26]
  Z. Zhou, J. Lv, H. Yu, et al., Mol. Cancer 19 (2020) 104. doi: 10.1002/fsn3.1272
27. [27]
  T. Sun, R. Wu, L. Ming, Biomed. Pharmacother. 112 (2019) 108613. doi: 10.1016/j.biopha.2019.108613
28. [28]
  F. Nie, P. Feng, X. Song, et al., Database (Oxford) 2020 (2020) baaa049. doi: 10.1093/database/baaa049
29. [29]
  M.E. Ritchie, B. Phipson, D. Wu, et al., Nucleic Acids Res. 43 (2015) e47. doi: 10.1093/nar/gkv007
30. [30]
  A. Subramanian, P. Tamayo, V.K. Mootha, et al., Proc. Natl. Acad Sci. U. S. A. 102 (2005) 15545-15550. doi: 10.1073/pnas.0506580102
31. [31]
  S. Hänzelmann, R. Castelo, J. Guinney, BMC Bioinformatics 14 (2013) 7. doi: 10.1186/1471-2105-14-7
32. [32]
  S. García-Mulero, M.H. Alonso, J. Pardo, et al., J. Immunother. Cancer 8 (2020) e000491. doi: 10.1136/jitc-2019-000491
33. [33]
  P. Charoentong, F. Finotello, M. Angelova, et al., Cell Rep. 18 (2017) 248-262. doi: 10.1016/j.celrep.2016.12.019
34. [34]
  B. Li, E. Severson, J.C. Pignon, et al., Genome Biol. 17 (2016) 174. doi: 10.1186/s13059-016-1028-7
35. [35]
  A.M. Newman, C.L. Liu, M.R. Green, et al., Nat. Methods 12 (2015) 453-457. doi: 10.1038/nmeth.3337
36. [36]
  F. Finotello, C. Mayer, C. Plattner, et al., Genome Med. 11 (2019) 34.
37. [37]
  D. Aran, Z. Hu, A.J. Butte, Genome Biol. 18 (2017) 220. doi: 10.1186/s13059-017-1349-1
38. [38]
  E. Becht, N.A. Giraldo, L. Lacroix, et al., Genome Biol. 17 (2016) 249. doi: 10.1186/s13059-016-1113-y
39. [39]
  R.R. Kotecha, R.J. Motzer, M.H. Voss, Nat. Rev. Clin. Oncol. 16 (2019) 621-633. doi: 10.1038/s41571-019-0209-1
40. [40]
  B. Ljungberg, L. Albiges, Y. Abu-Ghanem, et al., Eur. Urol. 75 (2019) 799-810. doi: 10.1016/j.eururo.2019.02.011
41. [41]
  R.R. Kotecha, R.J. Motzer, M.H. Voss, Nat. Rev. Clin. Oncol. 16 (2019) 621-633. doi: 10.1038/s41571-019-0209-1
42. [42]
  C.S. Huang, Q.C. Xu, C. Dai, et al., ACS Nano 15 (2021) 14744-14755. doi: 10.1021/acsnano.1c04570
43. [43]
  X. Chen, L. Zhao, Y. Kang, et al., Front. Pharmacol. 9 (2018) 118. doi: 10.3389/fphar.2018.00118
1. [1]
  Jiechen Liu , Xiaoguang Li , Ruiyang Xia , Yuqi Wang , Fenghe Zhang , Yongzhi Pang , Qing Li . Efficient suppression of oral squamous cell carcinoma through spatial dimension conversion drug delivery systems-enabled immunomodulatory-photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109619-. doi: 10.1016/j.cclet.2024.109619
2. [2]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
3. [3]
  Kun Zou , Yihang Xiao , Jinyu Yang , Mingxuan Wu . Facile semisynthesis of histone H3 enables nucleosome probes for investigation of histone H3K79 modifications. Chinese Chemical Letters, 2024, 35(10): 109497-. doi: 10.1016/j.cclet.2024.109497
4. [4]
  Chengde Wang , Liping Huang , Shanshan Wang , Lihao Wu , Yi Wang , Jun Dong . A distinction of gliomas at cellular and tissue level by surface-enhanced Raman scattering spectroscopy. Chinese Chemical Letters, 2024, 35(5): 109383-. doi: 10.1016/j.cclet.2023.109383
5. [5]
  Chenlu Huang , Xinyu Yang , Qingyu Yu , Linhua Zhang , Dunwan Zhu . Gas-generating polymersomes-based amplified photoimmunotherapy for abscopal effect and tumor metastasis inhibition. Chinese Chemical Letters, 2024, 35(6): 109680-. doi: 10.1016/j.cclet.2024.109680
6. [6]
  Junjie Wang , Yan Wang , Zhengdong Li , Changqiang Xie , Musammir Khan , Xingzhou Peng , Fabiao Yu . Triphenylamine-AIEgens photoactive materials for cancer theranostics. Chinese Chemical Letters, 2024, 35(6): 108934-. doi: 10.1016/j.cclet.2023.108934
7. [7]
  Xinyue Lan , Junguang Liang , Churan Wen , Xiaolong Quan , Huimin Lin , Qinqin Xu , Peixian Chen , Guangyu Yao , Dan Zhou , Meng Yu . Photo-manipulated polyunsaturated fatty acid-doped liposomal hydrogel for flexible photoimmunotherapy. Chinese Chemical Letters, 2024, 35(4): 108616-. doi: 10.1016/j.cclet.2023.108616
8. [8]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
9. [9]
  Xiaofang Luo , Ye Wu , Xiaokun Zhang , Min Tang , Feiye Ju , Zuodong Qin , Gregory J Duns , Wei-Dong Zhang , Jiang-Jiang Qin , Xin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724
10. [10]
  Zijian Jiang , Yuang Liu , Yijian Zong , Yong Fan , Wanchun Zhu , Yupeng Guo . Preparation of Nano Zinc Oxide by Microemulsion Method and Study on Its Photocatalytic Activity. University Chemistry, 2024, 39(5): 266-273. doi: 10.3866/PKU.DXHX202311101
11. [11]
  Shuyu Liu , Xiaomin Sun , Bohan Song , Gaofeng Zeng , Bingbing Du , Chongshen Guo , Cong Wang , Lei Wang . Design and Fabrication of Phospholipid-Vesicle-based Artificial Cells towards Biomedical Applications. University Chemistry, 2024, 39(11): 182-188. doi: 10.12461/PKU.DXHX202404113
12. [12]
  Ming Huang , Xiuju Cai , Yan Liu , Zhuofeng Ke . Base-controlled NHC-Ru-catalyzed transfer hydrogenation and α-methylation/transfer hydrogenation of ketones using methanol. Chinese Chemical Letters, 2024, 35(7): 109323-. doi: 10.1016/j.cclet.2023.109323
13. [13]
  Hongxia Li , Xiyang Wang , Du Qiao , Jiahao Li , Weiping Zhu , Honglin Li . Mechanism of nanoparticle aggregation in gas-liquid microfluidic mixing. Chinese Chemical Letters, 2024, 35(4): 108747-. doi: 10.1016/j.cclet.2023.108747
14. [14]
  Yixin Zhang , Ting Wang , Jixiang Zhang , Pengyu Lu , Neng Shi , Liqiang Zhang , Weiran Zhu , Nongyue He . Formation mechanism for stable system of nanoparticle/protein corona and phospholipid membrane. Chinese Chemical Letters, 2024, 35(4): 108619-. doi: 10.1016/j.cclet.2023.108619
15. [15]
  Wenlong Li , Feishi Shan , Qingdong Bao , Qinghua Li , Hua Gao , Leyong Wang . Supramolecular assembly nanoparticle for trans-epithelial treatment of keratoconus. Chinese Chemical Letters, 2024, 35(10): 110060-. doi: 10.1016/j.cclet.2024.110060
16. [16]
  Botao QU , Qian WANG , Xiaogang NING , Yuxin ZHOU , Ruiping ZHANG . Deeply penetrating photoacoustic imaging in tumor tissues based on dual-targeted melanin nanoparticle. Chinese Journal of Inorganic Chemistry, 2024, 40(5): 1025-1032. doi: 10.11862/CJIC.20230416
17. [17]
  Shenglan Zhou , Haijian Li , Hongyi Gao , Ang Li , Tian Li , Shanshan Cheng , Jingjing Wang , Jitti Kasemchainan , Jianhua Yi , Fengqi Zhao , Wengang Qu . Recent advances in metal-loaded MOFs photocatalysts: From single atom, cluster to nanoparticle. Chinese Chemical Letters, 2025, 36(1): 110142-. doi: 10.1016/j.cclet.2024.110142
18. [18]
  Lixian Fu , Yiyun Tan , Yue Ding , Weixia Qing , Yong Wang . Water–soluble and polarity–sensitive near–infrared fluorescent probe for long–time specific cancer cell membranes imaging and C. Elegans label. Chinese Chemical Letters, 2024, 35(4): 108886-. doi: 10.1016/j.cclet.2023.108886
19. [19]
  Jun Xiong , Ke-Ke Chen , Neng-Bin Xie , Wei Chen , Wen-Xuan Shao , Tong-Tong Ji , Si-Yu Yu , Yu-Qi Feng , Bi-Feng Yuan . Demethylase-assisted site-specific detection of N¹-methyladenosine in RNA. Chinese Chemical Letters, 2024, 35(5): 108953-. doi: 10.1016/j.cclet.2023.108953
20. [20]
  Tian Feng , Yun-Ling Gao , Di Hu , Ke-Yu Yuan , Shu-Yi Gu , Yao-Hua Gu , Si-Yu Yu , Jun Xiong , Yu-Qi Feng , Jie Wang , Bi-Feng Yuan . Chronic sleep deprivation induces alterations in DNA and RNA modifications by liquid chromatography-mass spectrometry analysis. Chinese Chemical Letters, 2024, 35(8): 109259-. doi: 10.1016/j.cclet.2023.109259

Get Citation

PDF

XML

Metrics

PDF Downloads(3)
Abstract views(395)
HTML views(22)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Nanoparticles targeting at methylases with high correlation to N6-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma

Metrics

通讯作者: 陈斌, bchen63@163.com

Nanoparticles targeting at methylases with high correlation to N⁶-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma